海南海药：子公司注射用美罗培南通过仿制药质量和疗效一致性评价

Core Viewpoint - Hainan Haiyao's subsidiary has received approval for the injectable drug Meropenem, which is used to treat various bacterial infections in adults and children [1] Group 1: Company Developments - Hainan Haiyao announced on November 14 that its wholly-owned subsidiary, Haikou Pharmaceutical Factory Co., Ltd., has obtained the approval from the National Medical Products Administration for the supplemental application of injectable Meropenem [1] - The approval includes a notification for the drug's use in treating infections caused by single or multiple bacteria sensitive to Meropenem [1] Group 2: Product Information - Injectable Meropenem is indicated for the treatment of pneumonia (including hospital-acquired pneumonia), urinary tract infections, intra-abdominal infections, gynecological infections (such as endometritis and pelvic inflammatory disease), skin and soft tissue infections, meningitis, and sepsis [1]